Hamps Bio Limited (BOM:544312)

India flag India · Delayed Price · Currency is INR
18.50
+0.50 (2.78%)
At close: Feb 12, 2026
Market Cap165.09M
Revenue (ttm)71.20M +3.0%
Net Income-1.63M
EPS-0.14
Shares Out8.71M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,000
Average Volume9,200
Open18.50
Previous Close18.00
Day's Range18.50 - 18.50
52-Week Range16.01 - 35.00
Betan/a
RSI48.93
Earnings DateFeb 13, 2026

About Hamps Bio

Hamps Bio Limited provides pharmaceutical, freeze dried, and frozen products in India and internationally. The company offers nutrition supplement, injection, pediatric care, toothpaste, mouth wash, antiacid/PPI, painkiller/anti-inflammatory, hematantic/calcium supplement, and antibiotic/antibacterial/antifungal pharmaceutical products. It also offers dry freeze food products, including ready to eat food, juices, ice cream powder, smoothie, tea, fruit snacks, milk related, and other dry food products. The company sells its products under the HA... [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 75
Stock Exchange Bombay Stock Exchange
Ticker Symbol 544312
Full Company Profile

Financial Performance

In fiscal year 2025, Hamps Bio's revenue was 66.69 million, an increase of 2.99% compared to the previous year's 64.75 million. Earnings were 2.98 million, a decrease of -40.53%.

Financial Statements